Skip to main content
Clinical Trials/NCT06604377
NCT06604377
Completed
Not Applicable

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features

Ruijin Hospital1 site in 1 country203 target enrollmentNovember 1, 2023
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Ruijin Hospital
Enrollment
203
Locations
1
Primary Endpoint
18F-PSMA-1007 PET/MR image parameters
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to investigate the predictive value of preoperative 18F-PSMA-1007 PET/MR in the predictive effect of biological recurrence (BCR) after radical prostatectomy (RP) for localized prostate cancer (PCa).

Detailed Description

Construct a predictive model for biochemical recurrence (BCR) in patients after radical prostatectomy using imaging parameters from preoperative 18F-PSMA-1007 PET/MRI, and compare the predictive performance of this model with existing clinical models. Data from three centers will be collected, with datasets from two centers used as the training set for the selection of predictive factors and model construction, while the dataset from the remaining center will serve as the validation set to assess the predictive performance of the model for BCR after prostatectomy.

Registry
clinicaltrials.gov
Start Date
November 1, 2023
End Date
June 30, 2024
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hu Jiajia

Head of Otolaryngology

Ruijin Hospital

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Histologically confirmed prostate cancer without other types of malignancy -

Exclusion Criteria

  • 1.Surgery or endocrine therapy is performed prior to the examination

Outcomes

Primary Outcomes

18F-PSMA-1007 PET/MR image parameters

Time Frame: Before surgery

Secondary Outcomes

  • Biochemical recurrence-free survival time(3 years)

Study Sites (1)

Loading locations...

Similar Trials